Cancer Genetics has been selected by AstraZeneca for a biotech deal to provide biomarker-based diagnostic testing for cancer.
CGI will perform complex testing for diagnosis and prognosis of cancer patients in Central America and the Caribbean.
CGI will work in close conjunction with AZ on exploring expansion opportunities into additional geographic territories, further oncology categories, and into select oncology trials.
For further deal information visit Current Agreements (subscription required)
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity